Embed this press release by copying the code below:
Actinium Pharmaceuticals, Inc. Launches Development of Antibody Actinium-225 Labeling Construct to Support Third Clinical Program
Actinium Pharmaceuticals, Inc. Launches Development of Antibody Actinium-225 Labeling Construct to Support Third Clinical Program